UVB is most effective for MF when the skin lesions consist of non-raised or barely raised lesions. UVA is required if the lesions are thick, because the shorter wavelengths of UVB do not penetrate ...

Cutaneous T-cell lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma that affects the skin. Here authors show that CDK9 degradation of retinoic acid receptor α is a vulnerability for CTCL and ...

The randomised, placebo-controlled FLASH2 trial aims to enrol nearly 80 patients with early-stage cutaneous T-cell lymphoma.

Soligenix begins confirmatory phase 3 trial of HyBryte for treatment of cutaneous T-cell lymphoma: Princeton, New Jersey Wednesday, December 18, 2024, 14:00 Hrs [IST] Soligenix, I ...

The most advanced candidate is poised for a potential accelerated approval for cutaneous T-cell lymphoma ... expression of KIR3DL2 on their skin lesions. Median progression-free survival was ...

His clinical and research activities focus on melanoma, cutaneous lymphoma, and immune dermatology ... a potent photosensitizer that is topically applied to skin lesions that is taken up by the ...

About a third of patients with diffuse large B cell lymphoma (DLBCL), a fast-growing form of lymphoma, will see their disease ...

In addition, patients with ulcerated skin lesions, particularly plaques or tumors, are at considerable risk for infection. With further progression, some of the abnormal T cells lose their skin ...

These malignant cells migrate to the skin where they form various lesions, typically beginning ... light for the treatment of cutaneous T-cell lymphoma (CTCL). With successful completion of ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...